Diabetes Mellitus Is a Strong Independent Negative Prognostic Factor in Patients with Brain Metastases Treated with Radiotherapy
暂无分享,去创建一个
E. Güresir | Johannes Wach | S. Klagges | P. Hambsch | Seong Jeong | Soniya Poudyal | Thomas Kuhnt | Kirsten Papsdorf | Franziska Nägler | Alexander Rühle | Nils H. Nicolay | Clemens Seidel | Nils H Nicolay | N. H. Nicolay | Thomas Kuhnt
[1] Angela Ishak,et al. Post-Diagnostic Statin Use and its Association with Cancer Recurrence and Mortality in Breast Cancer Patients: A Systematic Review and Meta-analysis. , 2023, European heart journal. Cardiovascular pharmacotherapy.
[2] O. Merimsky,et al. Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer , 2023, Cancer.
[3] J. Horbańczuk,et al. The Journey of Cancer Cells to the Brain: Challenges and Opportunities , 2023, International journal of molecular sciences.
[4] J. Sepúlveda,et al. Emerging targets for cancer treatment: S100A9/RAGE , 2023, ESMO open.
[5] D. Gladstone,et al. Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study. , 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] Zhengting Chen,et al. Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases , 2022, BMC Cancer.
[7] R. Soffietti,et al. Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism , 2022, Nature Medicine.
[8] A. Sahgal,et al. Intracranial Metastatic Disease: Present Challenges, Future Opportunities , 2022, Frontiers in Oncology.
[9] Wei Li,et al. Effects of Diabetes on Inflammatory Status and Prognosis in Cancer Patients , 2022, Frontiers in Nutrition.
[10] V. Gudnason,et al. Cerebrovascular Risk-Factors of Prevalent and Incident Brain Infarcts in the General Population: The AGES-Reykjavik Study , 2021, Stroke.
[11] S. Yadav,et al. Diabetes and Cancer: Risk, Challenges, Management and Outcomes , 2021, Cancers.
[12] M. Bernaudin,et al. Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy , 2021, Scientific Reports.
[13] S. Lo,et al. Risk-reduction strategies for late complications arising from brain metastases treated with radiotherapy: a narrative review. , 2021, Chinese clinical oncology.
[14] A. Sahgal,et al. Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study , 2020, Neuro-oncology advances.
[15] P. Vaupel,et al. Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study , 2020, Cancers.
[16] Yuankai Shi,et al. Prognostic value of pretreatment smoking status for small cell lung cancer: A meta‐analysis , 2020, Thoracic cancer.
[17] Chan Kwon Park,et al. Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer , 2020, BMC cancer.
[18] Mina Wang,et al. Diabetes and cancer: Epidemiological and biological links , 2020, World journal of diabetes.
[19] Gang Wu,et al. The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer , 2020, Translational lung cancer research.
[20] R. Ruslami,et al. Type 2 Diabetes and its Impact on the Immune System , 2020, Current diabetes reviews.
[21] B. S. Sørensen,et al. Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways , 2020, Frontiers in Oncology.
[22] P. Brown,et al. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. Townsend,et al. Hypertension in Cancer Patients and Survivors , 2019, JACC. CardioOncology.
[24] M. Bernaudin,et al. VCAM-1 targeted alpha-particle therapy for early brain metastases , 2019, Neuro-oncology.
[25] M. Bhat,et al. Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality , 2019, Cancers.
[26] Hengqiang Zhao,et al. High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway , 2019, Journal of Experimental & Clinical Cancer Research.
[27] K. Hoffmann,et al. Vascular white matter lesions negatively correlate with brain metastases in malignant melanoma—Results from a retrospective comparative analysis , 2019, Clinical Neurology and Neurosurgery.
[28] Han Liu,et al. Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer , 2018, Computational and structural biotechnology journal.
[29] N. Simone,et al. Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer , 2018, Breast Cancer Research and Treatment.
[30] H. Brenner,et al. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: A systematic review and meta-analysis. , 2018, Cancer treatment reviews.
[31] M. Preusser,et al. Anti-angiogenic therapies in brain metastases , 2018, memo - Magazine of European Medical Oncology.
[32] Eudocia Q Lee,et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study , 2017, Neuro-oncology.
[33] L. Collette,et al. Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001 , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] A. Akabane,et al. A Multi-institutional Prospective Observational Study of Stereotactic Radiosurgery for Patients With Multiple Brain Metastases (JLGK0901 Study Update): Irradiation-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores. , 2017, International journal of radiation oncology, biology, physics.
[35] T. Tsujimoto,et al. Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational study , 2017, International journal of cancer.
[36] G. Warren,et al. The Effects of smoking status and smoking history on patients with brain metastases from lung cancer , 2017, Cancer medicine.
[37] J. Potter,et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium , 2017, Diabetologia.
[38] W. Willett,et al. Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] K. Hoffmann,et al. White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study , 2016, Journal of Neuro-Oncology.
[40] Volker W Stieber,et al. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. , 2016, JAMA.
[41] R. Stupp,et al. Corticosteroids compromise survival in glioblastoma. , 2016, Brain : a journal of neurology.
[42] W. Feng,et al. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes☆,☆☆ , 2016, The American journal of the medical sciences.
[43] Wolfgang A Tome,et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] Satoshi Suzuki,et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. , 2014, The Lancet. Oncology.
[45] J. M. García-Martínez,et al. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose. , 2013, Journal of molecular endocrinology.
[46] G. Armstrong,et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] P. Brown,et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. , 2013, Neuro-oncology.
[48] D. Leroith,et al. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. , 2013, Endocrine-related cancer.
[49] S. Rosen,et al. Glucose transporters in cancer metabolism , 2012, Current opinion in oncology.
[50] S. Mathoulin-Pélissier,et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[51] Xianghua Luo,et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] S. Dalton,et al. Comorbidity and survival after early breast cancer. A review. , 2012, Critical reviews in oncology/hematology.
[53] A. Rojas,et al. Diabetes and cancer: Looking at the multiligand/RAGE axis. , 2011, World journal of diabetes.
[54] M. Mehta,et al. Presentation, patterns of care, and survival in patients with brain metastases , 2011, Cancer.
[55] D. Shibata,et al. Vascular risk factors and longitudinal changes on brain MRI , 2011, Neurology.
[56] K. Zänker,et al. Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation , 2010, British Journal of Cancer.
[57] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[58] B. Felding-Habermann,et al. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. , 2010, The American journal of pathology.
[59] A. Rojas,et al. Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. , 2010, Carcinogenesis.
[60] K. Hess,et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. , 2009, The Lancet. Oncology.
[61] P. Mazzone,et al. Small Vessel Ischemic Disease of the Brain and Brain Metastases in Lung Cancer Patients , 2009, PloS one.
[62] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[63] A. Wolff,et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. , 2008, JAMA.
[64] B. Zinman,et al. The impact of diabetes on survival following breast cancer , 2008, Breast Cancer Research and Treatment.
[65] M. Extermann,et al. Comprehensive geriatric assessment for older patients with cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] R. Soffietti,et al. Management of brain metastases , 2002, Journal of Neurology.
[67] M. Bousamra,et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.
[68] T. Kislinger,et al. N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.
[69] P. Wen,et al. Management of brain metastases. , 1999, Oncology.
[70] L Gaspar,et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.
[71] R. Strowd,et al. Impact of diabetes mellitus on outcomes in patients with brain metastasis treated with stereotactic radiosurgery. , 2018, Journal of radiosurgery and SBRT.
[72] F. Trimarchi,et al. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes. , 2018, Metabolism: clinical and experimental.
[73] D. Knopman,et al. Vascular risk factors and longitudinal changes on brain MRI The ARIC study , 2011 .
[74] Jochen Herms,et al. Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.